کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2568941 | 1128500 | 2013 | 10 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Ursolic acid improves domoic acid-induced cognitive deficits in mice Ursolic acid improves domoic acid-induced cognitive deficits in mice](/preview/png/2568941.png)
• Ursolic acid (UA) is a naturally triterpenoid compound.
• UA attenuated the mitochondrial dysfunction and cognitive deficits.
• Mechanistically, UA activates PI3K/Akt signaling and suppresses FoxO1 activity.
• UA could be recommended as a possible candidate for anti-excitotoxic brain disorders.
Our previous findings suggest that mitochondrial dysfunction is the mechanism underlying cognitive deficits induced by domoic acid (DA). Ursolic acid (UA), a natural triterpenoid compound, possesses many important biological functions. Evidence shows that UA can activate PI3K/Akt signaling and suppress Forkhead box protein O1 (FoxO1) activity. FoxO1 is an important regulator of mitochondrial function. Here we investigate whether FoxO1 is involved in the oxidative stress-induced mitochondrial dysfunction in DA-treated mice and whether UA inhibits DA-induced mitochondrial dysfunction and cognitive deficits through regulating the PI3K/Akt and FoxO1 signaling pathways. Our results showed that FoxO1 knockdown reversed the mitochondrial abnormalities and cognitive deficits induced by DA in mice through decreasing HO-1 expression. Mechanistically, FoxO1 activation was associated with oxidative stress-induced JNK activation and decrease of Akt phosphorylation. Moreover, UA attenuated the mitochondrial dysfunction and cognitive deficits through promoting Akt phosphorylation and FoxO1 nuclear exclusion in the hippocampus of DA-treated mice. LY294002, an inhibitor of PI3K/Akt signaling, significantly decreased Akt phosphorylation in the hippocampus of DA/UA mice, which weakened UA actions. These results suggest that UA could be recommended as a possible candidate for the prevention and therapy of cognitive deficits in excitotoxic brain disorders.
Journal: Toxicology and Applied Pharmacology - Volume 271, Issue 2, 1 September 2013, Pages 127–136